Drug delivery to the central nervous system (CNS) remains a challenge in neuro-oncology.Despite decades of research in this field, no consensus has emerged as to the best approach to tackle this physiological limitation.Moreover, the relevance of doing so is still sometimes questioned in the community.In this paper, we present our experience with C
Cisplatin, a chemotherapeutic drug, is known for causing gastrointestinal disorders and neuropathic pain, but its impact on visceral sensitivity is unclear.Monosodium glutamate (MSG) has been shown to improve gastrointestinal dysmotility and neuropathic pain induced by cisplatin in rats.This study aimed to determine if repeated cisplatin treatment
Regional and local governments worldwide are working tirelessly toward effective ways of addressing the COVID-19 crisis.During this time, the government has had to ensure that they provide full usage of technological means to confront the pandemic and Parts discourse a wide range of COVID-19 related problems.Herein, this article will discuss the ap
Bruno Schoenmaekers,1 Imad Derraz,2 Nadim Tahhan,3 Pierre Metrailler1 1Emergency Department, Centre Hospitalier du Valais Romand (CHVR), Sion, Switzerland; 2Department of Radiology, Centre Hospitalier du Valais Romand (CHVR), Sion, Switzerland; 3Neurosurgery Department, Centre Hospitalier du Valais Romand (CHVR), Sion, SwitzerlandCorrespondence: Br